Journal of Clinical Medicine of Kazakhstan is a peer-reviewed medical journal operating on a double-blind review system. The Journal follows the highest standards of publication ethics and takes all the necessary measures to prevent the publication misconduct.  All parties involved in the publication (publisher, editorial staff, peer reviewers and authors) are required to agree with our guidelines and standards to guarantee the highest quality research works.

We follow closely the principles of the Committee on Publication Ethics (, the International Committee of Medical Journal Editors (, and the World Association of Medical Editors (


Journal of Clinical Medicine of Kazakhstan adheres to the authorship criteria established by ICMJE ( Authorship should be limited to those who have made a significant contribution to the study’s conception, information collection, design, analysis, implementation, explanation or interpretation. Those who have made significant contributions should be listed as co-authors. All authors should participate in the development, revision, and approval of final version of the paper, and therefore accept responsibility for the work. Financial assistance, technical support or other contributions to the study from non-authors should be credited as an acknowledgement.

Disclosure and conflicts of interest

All authors of a manuscript submitted to the Journal of Clinical Medicine of Kazakhstan are required to declare any competing interests relevant to their study. Competing interests include a financial, commercial, legal, or professional relationship of the authors with other organizations or people working with them which could affect the research or interpretation of its results. Authors are required to complete the Conflict of Interest Form.  When the article is accepted for publication, the competing interests are disclosed in the Disclosure section at the end of the article before the references.


Journal of Clinical Medicine of Kazakhstan requires authors to declare any funding sources including financial support in their study. Authors should describe the role of sponsor, if any, at any stage of the research from design to submission of the manuscript for publication.

Informed consent

Necessary consents and permissions must be received from the participants of a study to ensure compliance with legislation and guidelines. Such consent is required to obtain and use personal information. Written informed consent must be acquired from the parent or guardian of any participants who are not able to provide full informed consent themselves (children, adolescents and vulnerable or incapacitated study participants). Signed consent forms should not be sent to the journal, but the authors should provide a declaration stating that informed consents were obtained from the participants.


Confidentiality of the information obtained during research is essential and such data should not be used without permission. Authors should take all required measures to secure information of participants, and protect the participants from any potential damage. Any information that may identify the participants should be removed from the manuscript.

Plagiarism and malpractice

Plagiarism, self-plagiarism, duplicate or multiple publications are improper actions that prohibited for authors. Also such unethical actions as fabrication, copyright breach, fraud, etc. must be avoided.

Authors should certify that the submitted manuscript is an original work, free of abovementioned malpractice, and adheres to ethical norms and applicable legislation. 

All submissions undergo an initial screening using iThenticate software to prevent plagiarism. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable.

Journal of Clinical Medicine of Kazakhstan practices the principle of single submission. It means that one submission of one manuscript to one journal at a time and no resubmission to another journal until a written rejection has been received. Submission of the same manuscript to more than one journal concurrently is prohibited.